reports
Warner Music Group Corp. Announces Quarterly Cash Dividend
Warner Music Group Corp. Announces Quarterly Cash Dividend NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Warner Music Group Corp. (“Warner Music Group” or “WMG”) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.17 per share on WMG’s Class A Common Stock and Class B Common Stock. The dividend is payable on June 3, 2024, to stockholders of record as of the close of business on May 23, 2024. About Warner Music Group With a legacy extending back over 200 years, Warner Music Group today is home to an unparalleled family of creative artists, songwriter...
Haitian International Holdings: 1 director
A director at Haitian International Holdings sold 204,000 shares at 27.764HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Mem...
Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024 With IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th most common diagnosis by all physicians, IBS represents a significant healthcare burden. inFoods IBS offers a groundbreaking method to identify foods that can trigger IBS symptoms, revolutionizing how IBS symptoms are managed. inFoods IBS is backed by extensive clinical research that ha...
Chang Lan Technology Group Co Ltd: 1 director
A director at Chang Lan Technology Group Co Ltd maiden bought 705,000 shares at 14.160CNY and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...
Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of S...
Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia – SENTI-202 is a potential first-in-class Logic Gated off-the-shelf CAR-NK cell therapy – – Initial clinical efficacy data expected by year-end 2024 and durability data expected in 2025 – SOUTH SAN FRANCISCO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circui...
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Pr...
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update -Positive Interim Clinical Trial Data for the First Oculopharyngeal Muscular Dystrophy (OPMD) Subject Dosed with BB-301 in the Phase 1b/2a Clinical Treatment Study Reported in April- -The Second OPMD Subject was Safely Dosed with BB-301 in February- -Additional Interim Clinical Safety Data and Clinical Efficacy Data are Expected for Several Study Subjects in the Second Half of 2024- -23 OPMD Subjects have Enrolled into the OPMD Natural History Study with Multiple Subjects Eligible for Entry i...
Royalty Pharma to Present at Upcoming Investor Conferences
Royalty Pharma to Present at Upcoming Investor Conferences NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of May: RBC Capital Markets 2024 Global Healthcare Conference on Tuesday, May 14 at 9:00 a.m. ETBofA Securities 2024 Healthcare Conference on Wednesday, May 15 at 6:00 p.m. ET / 3:00 p.m. PT The webcasts will be accessible from Royalty Pharma’s “Events” page at . Webcasts will also be archived for a minimum of thirty days. About Royalty Pharma Fou...
Ocean Power Technologies Announces Renewable Energy Production Milesto...
Ocean Power Technologies Announces Renewable Energy Production Milestone Approaches 15MWh of Renewable Energy Production MONROE TOWNSHIP, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, today announced it is approaching 15MWh of renewable energy production from its family of PowerBuoys ® (“PB”). The recent launch of its Next Generation PB off the coast of New Jersey has materially accelerated average energy production by co...
EQS-News: vbw Pressemitteilung: vbw 'Weißbier-Index' fällt im Frühjahr...
Emittent / Herausgeber: ibw – Informationszentrale der Bayerischen Wirtschaft e. V. / Schlagwort(e): Sonstiges/Sonstiges vbw Pressemitteilung: vbw 'Weißbier-Index' fällt im Frühjahr 2024 von 93 auf 87 Punkte 13.05.2024 / 14:07 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Pressemitteilung zum vbw Index Frühjahr 2024 vbw „Weißbier-Index“ fällt von 93 auf 87 Punkte Wirtschaft verharrt in Stagnation zunehmende Risiken für den Arbeitsmarkt Bundesregierung muss endlich den Schalter umlegen (München, 13.05.2024). Aus Sicht der vbw – ...
DFCC Bank: 1 director
A director at DFCC Bank bought 148,059 shares at 81.461LKR and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
- ABGSC Capital Goods Research
- Anders Idborg
- Karl Bokvist
- Olof Cederholm
Scandinavian Tobacco Group A/S: Transactions in connection with share ...
Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme Company Announcement No. 27/2024 Copenhagen, 13 May 2024 Transactions in connection with share buy-back programme On 10 November 2023, Scandinavian Tobacco Group A/S announced that a share buy-back programme of an aggregated value of up to DKK 850 million was launched with the purpose to adjust the Company’s capital structure and meet obligations relating to the Group’s share-based incentive programme. Part of the programme will be conducted in accordance with Regulation No. 596/2014 of the Eur...
- Mark Thomas
Hardman & Co Research on NB Private Equity Partners: Wider operating c...
We reviewed NBPE’s business model in our initiation, Co-investments generating superior performance. We noted the high-secular-growth and downside-resilient investee companies, the value added by GPs, the good co-investing cashflow and return profile and the value added by the NB. The 2023 results confirmed all these trends. The key numbers were i) NAV p/sh $28.07 (£22.02), ii) private portfolio +5.3% in 2023 on a constant currency basis, iii) EV/LTM EBITDA 14.9x, and iv) debt/EBITDA 5.3x. The p...
Hardman & Co Research on NB Private Equity Partners (NBPE): Wider oper...
Hardman & Co Research Hardman & Co Research on NB Private Equity Partners (NBPE): Wider operating company EBITDA margins in 2023 13-May-2024 / 13:07 GMT/BST The issuer is solely responsible for the content of this announcement. Hardman & Co Research | Investment Companies NB Private Equity Partners (NBPE) | Wider operating company EBITDA margins in 2023 We reviewed NBPE’s business model in our initiation, . We noted the high-secular-growth and downside-resilient investee companies, the value added by GPs, the good co-investing cashflow and return profile and the value add...
CNMC Goldmine Holdings Limited: 1 director
A director at CNMC Goldmine Holdings Limited sold 4,600,000 shares at 0.210SGD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
Moody's Ratings assigns provisional ratings to Consumer ABS Notes to b...
Moody's Ratings ("Moody's") has assigned the following provisional ratings to Notes to be issued by Mila 2024-1 B.V.: ....EUR [ ]M Class A asset-backed Notes 2024 due 2041, Assigned (P)Aaa (sf) ....EUR [ ]M Class B asset-backed Notes 2024 due 2041, Assigned (P)Aa3 (sf) ....EUR [ ]M Class C asset...
Cheetah Net Supply Chain Service Inc. Announces 1st Quarter 2024 Resul...
Cheetah Net Supply Chain Service Inc. Announces 1st Quarter 2024 Results and Provides Corporate Update CHARLOTTE, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Cheetah Net Supply Chain Service Inc. (“Cheetah” or the “Company”) (Nasdaq CM: CTNT), a supplier of parallel-import vehicles sourced in the U.S. to be sold in the People’s Republic of China (the “PRC”) market, today reported results for the quarter ended March 31, 2024 and provided a corporate update. Recent Highlights Challenging market conditions in the PRC, first reported with respect to the Company’s financial performance during the...
Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and...
Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates Interim data from initial dose escalation cohorts from Phase 1 CARDINAL trial of TERN-701 (allosteric BCR-ABL) in CML expected in 2H24 Top-line data from Phase 1 trial of TERN-601 (oral GLP-1) for obesity expected in 2H24 Cash, cash equivalents and marketable securities of $241 million, expected to provide runway into 2026 FOSTER CITY, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical stage biopharmaceutical company developing...
Graham Corporation Announces Filing of Universal Shelf Registration St...
BATAVIA, N.Y.--(BUSINESS WIRE)-- (NYSE: GHM) (“GHM” or “the Company”), a global leader in the design and manufacture of mission critical fluid, power, heat transfer and vacuum technologies for the defense, space, energy, and process industries, announced today that it has filed a universal shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC). If and when the shelf registration is declared effective, it will permit the Company to offer and sell, from time to time in one or more offerings, up to $150 million of common stock, preferred stock, warrants, purch...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.